Development of zona zoster during bortezomib treatment in patients with Relapsed/Refractory multiple myeloma

References (13)

1. Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP, Anderson KC. A phase 2 study of bortezomib in relapsed, refractory myeloma. NEJM 2003;348: 2609–17
2. Jagannath S, Richardson P, Barlogie B. Phase II trials of bortezomib in combination with dexamethasone in multiple myeloma (MM): assessment of additional benefits to combination in patients with sub-optimal responses to bortezomib alone. Proc Am S Clin Oncol 2003;22:582
3. Jagannath S, Barlogie B, Berenson J, Siegel D, Irwin D, Richardson PG, Niesvizky R, Alexanian R, Limentani SA, Alsina M, Adams J, Kauffman M, Esseltine DL, Schenkein DP, Anderson KC. A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol 2004;127:165–72
4. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Ann RevCell Biol 1994;10:405-55
5. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell 1996;87:13-20
6. Brown HJ, McBride WH, Zack JA, Sun R. Prostratin and borte zomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus. Antivir Ther 2005;10:745-51
7. Kroger N, Zabelina T, Ayuk F, Atanackovic D, Schieder H, Renges H, Zander A. Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status. Exp Hematol 2006;34:770-5
8. Cuzick J, De Stavola B. Multiple myeloma-a case-control study. Br J Cancer 1988;57:516-20
9. Ketterer N, Espinouse D, Chomarat M, Dumontet C, Moullet I, Rieux C, Neidhardt-Berard EM, Bouafia F, Coiffier B, Salles G. Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors. Am J Med 1999;106:191-7
10. Steingrimsdottir H, Gruber A, Kalin M, Bjorkholm M. Late infections after blood progenitor cell transplantation in patients with multiple myeloma. Am J Med 2001;110:329-30
11. Curley MJ, Hussein SA, Hassoun PM. Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma. J Clin Microbiol 2002;40:2302-4
12. Kropff MH, Bisping G, Wenning D, Volpert S, Tchinda J, Berdel WE, Kienast J. Bortezomib in combination with dexamethasone for relapsed multiple myeloma. Leuk Res 2005;29:587-90
13. San Miguel J, Blade J, Boccadoro M, Ca